These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1896809)

  • 1. Final report on a placebo-controlled, double-blind, randomized, multicentre trial of cyclosporin treatment in active chronic Crohn's disease.
    Brynskov J; Freund L; Nørby Rasmussen S; Lauritsen K; Schaffalitzky de Muckadell O; Williams CN; MacDonald AS; Tanton R; Molina F; Campanini MC
    Scand J Gastroenterol; 1991 Jul; 26(7):689-95. PubMed ID: 1896809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose cyclosporin for Crohn's disease: implications for clinical trials.
    Brynskov J; Binder V; Riis P; Lauritsen K; Schaffalitzky de Muckadell O; Freund L; Fallingborg J; Nørby Rasmussen S; Matzen P; Krag E
    Aliment Pharmacol Ther; 1989 Apr; 3(2):135-42. PubMed ID: 2491464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Crohn's disease in relapse with cyclosporin A.
    Parrott NR; Taylor RM; Venables CW; Record CO
    Br J Surg; 1988 Dec; 75(12):1185-8. PubMed ID: 3069176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.
    Brynskov J; Freund L; Rasmussen SN; Lauritsen K; de Muckadell OS; Williams N; MacDonald AS; Tanton R; Molina F; Campanini MC
    N Engl J Med; 1989 Sep; 321(13):845-50. PubMed ID: 2671739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
    Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
    Modigliani R; Colombel JF; Dupas JL; Dapoigny M; Costil V; Veyrac M; Duclos B; Soulé JC; Gendre JP; Galmiche JP; Danne O; Cadiot G; Lamouliatte H; Belaïche J; Mary JY
    Gastroenterology; 1996 Mar; 110(3):688-93. PubMed ID: 8608877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cyclosporin A in acute Crohn disease: initial findings].
    Marbet UA; Gyr K; Stalder GA
    Schweiz Med Wochenschr; 1986 Jul; 116(29):962-3. PubMed ID: 3764377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin.
    Prantera C; Lochs H; Campieri M; Scribano ML; Sturniolo GC; Castiglione F; Cottone M
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1117-25. PubMed ID: 16611272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin.
    Brynskov J; Tvede N
    Gut; 1990 Jul; 31(7):795-9. PubMed ID: 2370014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin as initial treatment for Crohn's disease.
    Nicholls S; Domizio P; Williams CB; Dawnay A; Braegger CP; MacDonald TT; Walker-Smith JA
    Arch Dis Child; 1994 Sep; 71(3):243-7. PubMed ID: 7979499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled double blind study of azathioprine in the management of Crohn's disease.
    Candy S; Wright J; Gerber M; Adams G; Gerig M; Goodman R
    Gut; 1995 Nov; 37(5):674-8. PubMed ID: 8549944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Crohn disease: initial experiences with cyclosporin A in an adolescent girl].
    Dannecker G; Malchow H; Niessen KH; Ranke MB
    Dtsch Med Wochenschr; 1985 Mar; 110(9):339-43. PubMed ID: 2857635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cyclosporin A on active Crohn's disease.
    Fukushima T; Sugita A; Masuzawa S; Yamazaki Y; Tsuchiya S
    Gastroenterol Jpn; 1989 Feb; 24(1):12-5. PubMed ID: 2651204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine for induction of remission in Crohn's disease.
    McDonald JW; Feagan BG; Jewell D; Brynskov J; Stange EF; Macdonald JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD000297. PubMed ID: 15846602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European trial of cyclosporine in chronic active Crohn's disease: a 12-month study. The European Study Group.
    Stange EF; Modigliani R; Peña AS; Wood AJ; Feutren G; Smith PR
    Gastroenterology; 1995 Sep; 109(3):774-82. PubMed ID: 7657105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of anti-tuberculous chemotherapy for two years in Crohn's disease.
    Swift GL; Srivastava ED; Stone R; Pullan RD; Newcombe RG; Rhodes J; Wilkinson S; Rhodes P; Roberts G; Lawrie BW
    Gut; 1994 Mar; 35(3):363-8. PubMed ID: 8150348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study.
    van Rijthoven AW; Dijkmans BA; Goei The HS; Hermans J; Montnor-Beckers ZL; Jacobs PC; Cats A
    Ann Rheum Dis; 1986 Sep; 45(9):726-31. PubMed ID: 3532966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of budesonide with prednisolone for active Crohn's disease.
    Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
    N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study.
    Feagan BG; Sandborn WJ; D'Haens G; Panés J; Kaser A; Ferrante M; Louis E; Franchimont D; Dewit O; Seidler U; Kim KJ; Neurath MF; Schreiber S; Scholl P; Pamulapati C; Lalovic B; Visvanathan S; Padula SJ; Herichova I; Soaita A; Hall DB; Böcher WO
    Lancet; 2017 Apr; 389(10080):1699-1709. PubMed ID: 28411872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease.
    Ewe K; Press AG; Singe CC; Stufler M; Ueberschaer B; Hommel G; Meyer zum Büschenfelde KH
    Gastroenterology; 1993 Aug; 105(2):367-72. PubMed ID: 8335191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.